Margin power masks volume miss; new capacity delayed
Greenply delivered 11.2% operating margins (+300 bps YoY) despite 700+ bps raw material cost inflation—a genuine operational win. But the company cut MDF volume guidance (25–30% → ~20%), and both segments missed in the quarter. Capacity relief is delayed to Q4 FY28.
₹42.7 Cr
+167% YoY
₹89.2 Cr
11.2% OPM, +300 bps YoY
₹544 Cr
D/E 0.56x, well below 0.75x peak
The quarter in one line: margins beat, volumes stumbled, guidance cut
Greenply hit its operating margin targets—11.2% in Q2, +300 bps year-over-year—while absorbing 700+ basis points of raw material cost inflation. That's the real story: the company's operational leverage and premium product mix (Ecotec, TermiVax anti-termite) are genuine. But the headline is shadowed by two volume misses and a cut to full-year guidance. MDF volume growth fell to 16.1% in Q2 (half of the 25–30% FY27 target the company had guided) due to monsoon and maintenance disruptions. Plywood, fully utilized at >100%, grew only 6.1% volume YoY—well short of the 10% annual target. Management has since cut MDF FY27 growth guidance to ~20%, which H1 tracking suggests is achievable, but the gap between prior guidance and current performance is material.
Where profit actually came from
Reported PAT surged 167% to ₹42.7 Cr, but the growth is partly optical. The operating segments delivered core EBITDA of ₹89.2 Cr (11.2% OPM), holding firm despite inflationary headwinds. However, the SAMET joint venture (furniture making, 50-50 with Saloni) dragged consolidated profit: the JV posted a PAT loss of ₹12.6 Cr in Q2, of which Greenply's share was ₹6.3 Cr. This JV drag narrows consolidated NPM to just 5.3%, masking the strength of the core business. The company stopped funding the JV in Q1; the partner now handles operations and funding via advances. More importantly, Greenply is diluting its stake to 20% effective January 5, 2027, which will shift the unit to a brand-charge model and significantly reduce the drag on consolidated earnings.
Management's claims vs. what holds up
Maintain plywood 10% annual volume growth
Q2: 6.1% YoY (capacity-constrained at >100% utilization); H1: 9.2% YoY on track for FY if H2 delivers >11%
Overstated—execution risk
MDF 25–30% volume growth for FY27
Q2: 16.1% YoY; H1: 20.4% YoY. Management revised down to ~20% on this call.
Contradicted—guidance cut
Deliver 11–12% operating margins
Delivered 11.2% OPM in Q2, holding despite 700+ bps raw material cost inflation.
Supported—operational excellence
Debt-to-equity 0.56x, well below 0.75x peak guidance
Net debt ₹544 Cr, D/E confirmed 0.56x. On track to 0.65x by FY28 year-end per guidance.
Supported—discipline confirmed
FY27 capex ₹500 Cr on track
Plywood expansion (₹125 Cr, 15M sq m) to start Q4 FY28 at Sandila/Lucknow. MDF Vadodara/Odisha Q2 FY28. On track.
Supported—capex pacing normal
What changed on this call
1. MDF guidance downward revised. Prior call: 25–30% FY27 MDF volume growth. Q2 call: ~20% (H1 tracking 20.4% YoY, Q2 dipped to 16.1% due to monsoon and planned maintenance). The miss is execution-related, not demand-related; management remains confident on brand strength and pricing power. 2. Plywood margin expansion. Core EBITDA margin on plywood hit 10.05% in Q2 (+180 bps QoQ, +160 bps YoY), driven by Ecotec premium mix (TermiVax anti-termite and pre-lam volume) and operational efficiency despite inflation. This is a genuine operational upgrade. 3. Strategic shift: exiting SAMET JV. Greenply is diluting from 50-50 to ~20% stake effective January 5, 2027. The partner (Saloni) now funds operations; Greenply shifts to a brand-charge model. This removes a major consolidated earnings drag and clarifies the capital structure. 4. New revenue streams ramping. HDF flooring line (Odisha) commenced July 2026 and is ramping in Q2 FY27. Chipboard manufacturing (asset-light, <₹100 Cr capex) planned for next year or next-to-next year. These are new levers to drive growth beyond plywood/MDF.
OPM +300 bps YoY to 11.2%; genuine operational leverage
Premium mix (TermiVax, Ecotec) working; realisation ₹264/sq m plywood
New capex pipeline: ₹125 Cr plywood (₹320 Cr revenue potential), MDF Vadodara/Odisha
Net debt ₹544 Cr (D/E 0.56x) well below peak; capex self-funding
MDF volume guidance cut (25–30% → 20%); execution risk
Plywood capacity >100% utilized; Q2 volume growth only 6.1%
New capacity relief delayed to Q4 FY28; near-term growth capped
Competitive intensity rising (Elixir, Action TESA); margin pressure possible
JV dilution to 20% (Jan 5) removes consolidated drag, but timing in future
How the street is positioned
Price & valuation: The stock trades at ₹264.7 (as of 2026-11-02), down 35.74% from its all-time high of ₹411.95 but recovered +50.04% off the 52-week low of ₹176.42. It sits below the 20- and 50-day simple moving averages (₹300.13 and ₹294.88, respectively) but above the 200-day SMA of ₹264.03. The RSI of 34.2 suggests neutral momentum—neither deeply oversold nor overbought. The large drawdown from ATH reflects the market's repricing of growth and capex intensity; the stable positioning above the 200-day average suggests a floor is holding. Institutional flows: Foreign institutional investors (FII) stand at 4.44% (up +25 bps from 4.19% in the prior quarter), showing modest accumulation. Domestic institutional investors (DII) are at 31.43% (down −40 bps from 31.83%), stable long-term. Promoter stake unchanged at 51.93%. No insider selling signal in recent bulk/block deals; the most recent activity (April 2026) was at ₹286–288, and the current price of ₹264.7 is below that level. The absence of promoter/insider-linked selling near the highs is a subtle positive signal. Volume trend: Trading volume is increasing, which can signal base-building or accumulation. The combination of FII accumulation, DII stability, rising volume, and no insider selling suggests institutional investors are not panicking despite the guidance cut and 35% drawdown.
Risks, ranked by how much they should concern a holder
MDF volume misses FY27 20% target
MediumMDF is higher-margin (15–16% EBITDA); shortfall below 20% would signal brand/competitive weakness, not just seasonality. Guidance miss two quarters in a row would erode credibility.
Plywood H2 growth <11% (needed to hit 10% annual target)
MediumCapacity is already >100% utilized. If H2 demand softens or Odisha ramp delays, full-year target slips. Signals structural capacity headwind, not temporary disruption.
Sandila expansion (₹125 Cr capex, Q4 FY28 start) delayed or underperforms
MediumThis expansion anchors long-term growth narrative and ROIC assumptions. Delays or low utilization would push ROI down and extend capacity-constrained period.
Margin compression from competitive intensity (Elixir, Action TESA, pricing wars)
MediumMDF is entering a more competitive phase. If pricing power erodes faster than new entrants consolidate, margins could compress to 12–13%, wiping out the operational leverage story.
Chemical cost inflation sustained at 7–8% or rises further
LowManagement confident on passing through via product mix (Pre-lam premium). But if raw costs spike unexpectedly and mix reverts to plain boards, margin buffer shrinks.
SAMET JV dilution (Jan 5) hits execution bumps
LowJan 5 date is firm, but if dilution is contested or partner cannot take on full funding, consolidated drag persists longer.
What to watch next
1 · H2 FY27 volume delivery (Plywood >11%, MDF >18% growth)
The company needs >11% plywood volume growth in H2 to hit the 10% annual target, and MDF must stay >18% to average 20% FY27. These are the proof points that monsoon/maintenance were temporary, not structural. Odisha plywood ramp-up and continued Ecotec traction must show up here.
2 · Odisha plywood line ramp-up (Q3–Q4 FY27) and utilization
If the new line ramps smoothly and hits >80% utilization by Q4, it signals execution capability and near-term capacity relief. Slow ramp or soft utilization would flag capex ROI and execution risk on future Sandila expansion.
3 · SAMET JV dilution closure (Jan 5) and Q3 consolidated earnings
Dilution to 20% stake should cut the JV drag in half or more. Q3 consolidated PAT (post-dilution) should widen the gap between reported PAT and core EBITDA. If it doesn't, look for hidden issues in the JV transition or partner funding.
The number to track
From here, the single most important metric is core EBITDA margin hold. If Greenply can keep OPM at 10–11% through H2 FY27 and into FY28, despite new competitive entrants and any margin pressure from cost inflation, then the margin-expansion thesis is credible. A slip below 10% would signal that the operational leverage story is cracking.
Greenply is a steady operator in a structurally growing market (organized plywood/MDF taking share from unorganized). The Q2 beat on operating margins is genuine, and the capex roadmap (new plywood, MDF, flooring) is credible. But the volume guidance miss and the admission of execution challenges (monsoon, capacity, competitive intensity) mean near-term growth is constrained. The stock's 35% drawdown from ATH is pricing in both the guidance cut and the capex cycle ahead. At current levels, this is a HOLD: not a buy for growth, and not a sell for value. Execution on H2 FY27 volumes and Odisha ramp-up will determine whether the stock reprices back toward ATH or consolidates lower. The JV dilution (Jan 5) is a near-term catalyst to watch for earnings clarification.
Greenply Q2 FY27: PAT surges 167% YoY to ₹42.7 Cr as margins expand on MDF turnaround
PAT +167.37% YoY · revenue +16.14% · margins expanding
₹799.69 Cr
+16.14% YoY
₹42.73 Cr
+167.37% YoY
5.32%
+3pp YoY
₹3.42
Greenply's consolidated PAT jumped 167.4% YoY to ₹42.73 Cr (from ₹15.98 Cr) on revenue of ₹799.69 Cr, up 16.1% YoY — profit growth running far ahead of topline, the hallmark of this quarter. Sequentially, PAT rose a steadier 13.6% QoQ (₹37.61 Cr in Q1 FY27) on 10.3% revenue growth, consistent with the margin trend rather than a seasonal spike. Standalone PAT rose 72.9% YoY to ₹31.47 Cr on 13.5% revenue growth to ₹591.58 Cr — healthy, but far short of the consolidated pace, a >3% divergence that readers should note: the gap sits almost entirely in the MDF subsidiary, which standalone numbers exclude.
Q2 FY-2027 vs prior quarters
The margin bridge is the real story. Consolidated OPM (EBITDA margin) expanded to 11.16% from 8.24% a year ago (+292 bps) and from 10.80% last quarter; NPM rose to 5.34% from 2.32% YoY. By segment, MDF and allied products swung to a segment result of ₹20.15 Cr from just ₹4.32 Cr a year ago (+366%) on 18.4% revenue growth to ₹173.90 Cr — last year's quarter had been depressed by discounted liquidation of slow-moving MDF inventory, so this is a genuine turnaround off a weak base. Plywood, the larger segment, grew segment result 40.6% YoY to ₹54.65 Cr on 15.6% revenue growth to ₹626.14 Cr. Lower finance costs (₹11.12 Cr vs ₹13.49 Cr YoY) and a lower effective tax rate (24.9% vs 31.4% YoY) added further to the bottom line.
The stock went into the print at ₹303.7, up 8.6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
No exceptional items this quarter (unlike FY26 quarters with MDF-Dubai JV and labour-code one-offs) — YoY comparison is clean
FY27 targets: 10% plywood volume growth, 25-30% MDF volume growth, FY27 capex ₹500 Cr. Peak debt ~₹725 Cr by March 2027 (D/E 0.75x), then gradual reduction to 0.65x by year-end FY28.
Management's prior guidance (FY27 concall) called for 10% plywood volume growth, 25–30% MDF volume growth, ₹500 Cr FY27 capex, and peak debt of ~₹725 Cr (0.75x D/E) by March 2027. This filing doesn't break out volumes, so the targets can't be confirmed directly; using segment revenue as a rough proxy, plywood's 15.6% growth is comfortably ahead of its 10% volume goal while MDF's 18.4% revenue growth trails the 25–30% volume range (price/mix could narrow or widen that gap either way). Consolidated debt stands at ₹576.9 Cr (D/E ~0.60x) versus ₹489.2 Cr at March-26 — rising as guided, and still below the ~₹725 Cr peak flagged for March 2027. No quarter-specific Street estimate could be located (results were announced today); full-year FY27 consensus has pegged ~43% EPS growth (Sharpely), a pace this single quarter's 167% PAT growth already outruns. No standalone press release accompanies this filing — the outcome-of-board-meeting letter covers only capacity expansion, remuneration revisions and auditor rotation, not quarter commentary, so there is no fresh management framing of the print to reconcile against.
W1
MDF volume/margin trajectory against the 25-30% FY27 volume guidance — Q2 MDF segment revenue grew only 18.4% YoY, trailing that range
W2
Consolidated debt (₹576.9 Cr at Sept-26, D/E ~0.60x) versus the guided peak of ~₹725 Cr (0.75x) by March 2027 as Sandila and other capex spend through FY27-28
W3
OPM sustainability into H2 (currently 11.16%) as the new Sandila capacity ramps toward Q4 FY28 completion
Clean digital filing, unambiguous columns. Consolidated PBT nets a ₹6.32 Cr share of loss from equity-accounted JV/associate; of total PAT ₹42.73 Cr, ₹42.62 Cr is owners' share and ₹0.11 Cr NCI. No exceptional items in either this quarter or the year-ago quarter column (unlike FY26 quarters which carried MDF-Dubai JV and labour-code one-offs), so YoY PAT comparison is like-for-like with no adjustment needed.
Strong margins, volume growth cut—capacity relief delayed
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit margins; missed/cut MDF volume guidance; capex on track; debt below 0.75x target. Candid on constraints.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Greenply delivered strong margin expansion (OPM 11.2%, +300 bps YoY) and held profitability despite 700+ bps raw cost inflation through premium mix and operational leverage. However, MDF volume guidance was cut from 25-30% to ~20%, and Plywood Q2 growth lagged at 6.1% YoY due to capacity constraints. New capacity relief is delayed to Q4 FY28. Premium positioning and brand strength are genuine, but execution risk on new plants and near-term growth headwinds warrant caution.
₹799.7 Cr
Revenue · +16.1% YoY₹42.7 Cr
Reported PAT · +167.3% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Maintain plywood 10% volume growth target
OVERSTATEDQ2: 6.1% YoY (capacity-constrained), H1: 9.2% YoY (on track for FY)
MDF 25-30% volume growth for FY27
MISSQ2: 16.1% YoY, H1: 20.4% YoY; guidance revised down to ~20%
Deliver 11-12% operating margins
METOPM 11.2% in Q2, holding despite 700+ bps raw material cost inflation
PAT growth 167% YoY
METDelivered ₹42.7 Cr vs ₹16 Cr prior year (but from low base; NPM 5.3%)
Net debt 0.56x, well below 0.75x target
METNet debt ₹544 Cr, D/E 0.56x confirmed
Earnings quality
What changed since the last call
MDF volume guidance downward revised
DowngradePrior call: 25-30% FY27 MDF growth. Q2 call: ~20% FY27 growth (H1 tracking 20.4% YoY, Q2 16.1% YoY due to monsoon/maintenance disruptions).
Plywood margin expansion
UpgradeQ2 core EBITDA margin 10.05% (+180 bps QoQ, +160 bps YoY), driven by Ecotec premium mix (TermiVax traction) and operational efficiency despite inflation.
MDF margin guidance maintained
NeutralHolding 15-16% core EBITDA margin on MDF despite 700+ bps chemical cost inflation; product mix (Pre-lam volume +volume, plain boards down) offsetting costs.
Net debt trajectory reaffirmed
NeutralD/E 0.56x at Q2 (well below 0.75x peak guidance, on track to 0.65x by FY28 year-end). ₹544 Cr net debt stable.
The Q&A
Q&A tone was scrutinizing but management held firm. Analysts pressed on MDF margin sustainability under cost inflation (Sneha, Nuvama), capacity adequacy (Karan, Asian Markets), and SAMET JV drag (Parth, Investec). Management candid: margins held via mix/efficiency, no new capacity fears post-Odisha, JV now partner-funded with Greenply reducing drag. Few deflections; mostly direct answers with caveats on timing.
Plywood strategy amid volume miss — Karan Bhatelia, Asian Markets
AnsweredNo shift. Plant utilization >100%, capacity will be challenge for us. Premium strategy continues; Ecotec very strong. TermiVax campaign boosted premium segment. Once Odisha/Sandila start, capacity will be challenge post-Odisha in two, four, five quarters.
MDF margin guidance under cost inflation — Akshay Chheda, Canara Robeco
PartialConfident 15%, 16% EBITDA will be delivered. Production ramps 60,000 cubic meters per quarter. Operational efficiencies, flooring/insulation coming soon. All of that should improve.
MDF volume growth trajectory — Sneha, Nuvama
AnsweredProduction 53k, sales 54k. Production challenge due to monsoons, maintenance (four days instead of one). Not external. Competitive scenario increasing. Smaller players dying; Elixir, Action TESA starting. But brand strong; we'll sell MDF at operating price. No challenge.
Pricing power amid cost pass-through — Sneha, Nuvama
AnsweredIncrease has sustained. 7-8% hit on cost from chemicals. Everything else stable. Better product mix (Pre-lam up, plain boards up). Replacing plain with Pre-lam. Margins stay where we guided.
SAMET JV dilution and drag — Parth Bhavsari, Investec
AnsweredJan 5 end date for dilution to 19-20%. Stopped funding Q1; partner funds it in advances. Drag from line-item entry only. No further provision required; consol already reflects prior losses.
Carbon credit monetization scope — Ritesh Shah, Investec
Partial50-60% sourcing from Vadodara/Nagaland via program. 100% sourcing in Nagaland currently. Credits registered till '23, next tranche till '26. Monetization: ~USD 15 per credit = ~INR 25-30 Cr revenue. Minuscule economically; focus is farmer income, not Greenply profit.
Chipboard manufacturing entry — Rishab Bothra, Systematix
PartialMulti-delight line alongside MDF, asset-light vs Conti line. Capex <INR100 Cr. Asset turn 1:2, partic. board upside. Next year or next-to-next year depending on bandwidth.
Plywood H2 growth confidence — Shruti Mulchandani, Ikigai
PartialH1 had very disturbed Q1. H2 higher plan, very confident annual >10% volume growth. Odisha/Sandila ramp Q3/Q4. 63,000 CBM quarterly requirement Q3/Q4 doable with sales-wise. Flooring starting H2.
MDF capacity addition timeline and growth — Shruti Mulchandani, Ikigai
Partial66,000 CBM quarterly requirement Q3/Q4 possible. Inventory in hand now. Selling flooring H2. Revenue INR60k per CBM roughly. Sandila Ply capex INR320 Cr at 15M sq m, realistic projection INR220. Multi-delight chipboard later (lower capex, high asset turn).
MDF industry ROE and new entrant risk — Praveen Agarwal, Individual
AnsweredReturn levels low today due to margin/capacity constraints. New entrants dying (Elixir 3y ago). No new large entrant attracted. Smaller players have no situation to backtrack. Greenply riding tiger; tiger must keep growing else eaten. Confidently 18%+ ROE on MDF 3-5y basis.
Guidance
FY27 plywood volume ~10% annual growth
MediumH1 tracking 9.2% YoY; Q2 6.1% YoY due to capacity constraints at >100% utilization. Odisha/Sandila ramp Q3/Q4 should enable target by year-end.
FY27 MDF volume ~20% growth (revised from 25-30%)
MediumH1 tracking 20.4% YoY; Q2 16.1% YoY due to monsoon/maintenance disruption. Capacity (60k CBM/quarter) adequate if no supply shocks; new lines Vadodara/Odisha Q2 FY28.
FY27 capex ₹500 Cr
HighOn track. Plywood expansion ₹125 Cr (15M sq m Sandila/Lucknow, Q4 FY28 start), MDF Vadodara/Odisha, HDF flooring Odisha (live July 2026).
Plywood EBITDA margin 10-11% (OPM 11.2% in Q2)
HighQ2 10.05%, H1 9.31%; mix shift (Premium/Ecotec/TermiVax) + operational leverage driving expansion. Expected to hold/improve as new capacity comes in with higher realisation.
MDF EBITDA margin 15-16% (Q2 15.2%, H1 16.3%)
HighHolding despite 7-8% chemical cost inflation via product mix (Pre-lam volume +, plain boards down) and operational efficiency gains. Confidence high going forward as new capacity brings operational scale.
FY27 capex ₹500 Cr
HighPlywood (Sandila Lucknow): ₹125 Cr, 15M sq m, commercial production Q4 FY28, ₹320 Cr revenue potential. MDF Vadodara/Odisha Q2 FY28. Chipboard <₹100 Cr next year or next-to-next year.
Risks the call surfaced
Volume growth shortfall
MediumMDF monsoon/maintenance in Q2 cut volume 16.1% YoY; H1 20.4% tracking target but execution risk remains. Plywood Q2 6.1% YoY due to capacity constraints; H1 9.2% implies H2 must deliver >11% to hit 10% annual.
Margin compression risk
MediumChemical costs up 7-8% sustained; Q1 price hike 15.5% rolled back in Q2 per earlier commentary. Product mix (Premium/Pre-lam) offsetting, but risk if mix reverts to plain boards or price wars intensify.
JV drag on consolidated profitability
HighSAMET JV reported PAT loss ₹12.6 Cr Q2, Greenply share ₹6.3 Cr; H1 loss ₹24.2 Cr total (₹12.1 Cr Greenply share). Diluting consolidated NPM to 5.3% despite strong 11.2% OPM. Dilution to 20% stake Jan 5, 2027 will reduce drag, but near-term earnings pressure remains.
Capacity execution risk
MediumPlywood expansion (15M sq m at Sandila/Lucknow) expected Q4 FY28 start; budgeted ₹125 Cr capex with ₹320 Cr revenue potential (₹340 Cr base case). MDF Vadodara/Odisha Q2 FY28. Delays or operational ramp inefficiencies could push out return trajectory.
Debt refinancing / leverage risk
LowNet debt ₹544 Cr, D/E 0.56x well below 0.75x peak guidance. But FY27 capex ₹500 Cr + planned ₹125 Cr plywood expansion (FY28+) will raise debt. Management target 0.65x by FY28 year-end, achievable if earnings growth continues.
Management
Score 7/10. Clear articulation of plywood/MDF growth levers (product mix, technology, capacity). Candid on monsoon/maintenance headwinds; did not hide volume miss. Transparent on MDF guidance revision (25-30% → ~20%). Track record mixed: margins hit targets (+300 bps OPM YoY), but Plywood volume (9.2% H1 vs 10% target) and MDF (20.4% H1 vs prior 25-30% guidance) fell short. Capex execution on track. Debt discipline (0.56x vs 0.75x target) strong.
1 · Q4 FY28
New plywood capacity (15M sq m) at Sandila/Lucknow, ₹125 Cr capex, ₹320 Cr revenue potential
2 · Q2 FY28
New MDF facility at Vadodara and Odisha, expected to drive FY28 growth
3 · H2 FY27
Odisha plywood line ramp-up and continued Ecotec (Green, Premium) volume growth via TermiVax, pre-lam mix shift
Premium positioning and brand strength are genuine, but execution risk on new plants and near-term growth headwinds warrant caution.